Refresh

Jagjanani Textiles Ltd.

Price on BSE   09 Apr,15:17 LIVE
8.00
-0.04
(-0.50%)

© 2025 Rediff.com
  • Volume :
  • 22,939.00
  • Prev Close :
  • 8.04
  • Day's H/L (Rs.) :
  • 8.25 - 7.60
  • 52wk H/L (Rs.) :
  • 18.87 - 7.00
  • Mkt Cap (Rs. Cr) :
  • 12.49
Jagjanani Textiles Ltd. is not listed on NSE

© 2025 Rediff.com
Report Card - Jagjanani Textiles Ltd.
PE Ratios
3.25
EPS (Rs.)
2.46
Sales (Rs. Cr)
Face Value (Rs.)
10
Net Profit Margin(%)
Last Bonus
-
Last Dividend(%)
-
Return on Average Equity
4870.17

Sector News

Biocon Biologics Gets USFDA Approval for Cancer Biosimilar - Jobevne
Biocon Biologics receives USFDA approval for Jobevne (bevacizumab-nwgd), a biosimilar Bevacizumab for treating various cancers. This approval expands the company's biosimilar oncology portfolio in...
Apr 10, 2025 11:16
Xindus Raises $10 Million for Cross-Border Trade Expansion
Xindus, a full-stack cross-border trade startup, secures $10 million in Series A funding to scale operations, onboard 10,000 customers, and expand its reach across global markets.
Apr 10, 2025 11:01
Indian Job Market Resilient Despite Global Uncertainties
India's job market remains strong, driven by tech expertise, cost efficiency and upskilling, says Michael Page India. Learn about key sectors seeing hiring surges.
Apr 10, 2025 10:53
India Should Reconsider US Trade Pact: GTRI
Think tank GTRI advises India to reconsider a comprehensive trade deal with the US, suggesting a limited zero-to-zero tariff agreement on industrial goods instead. The group warns of potential...
Apr 10, 2025 10:07
US Tariff Pause: Relief for Indian Exporters, Trade Talks Open
US delays tariffs on India, giving exporters a 90-day window for trade talks. The move provides a chance to negotiate a trade agreement and potentially double trade by 2023.
Apr 10, 2025 09:32

More News »

Top News

Biocon Biologics Gets USFDA Approval for Cancer Biosimilar - Jobevne
Biocon Biologics receives USFDA approval for Jobevne (bevacizumab-nwgd), a biosimilar Bevacizumab for treating various cancers. This approval expands the company's biosimilar oncology portfolio in...
Apr 10, 2025 11:16
Nimbuspost Appoints Irwin Anand as CEO
Nimbuspost, a logistics tech platform and Xpressbees subsidiary, has appointed Irwin Anand as its new CEO. Anand, formerly MD of Udemy India & APAC, will focus on product innovation, seller...
Apr 10, 2025 11:15
Xindus Raises $10 Million for Cross-Border Trade Expansion
Xindus, a full-stack cross-border trade startup, secures $10 million in Series A funding to scale operations, onboard 10,000 customers, and expand its reach across global markets.
Apr 10, 2025 11:01
Omega Seiki Offers Pink Electric Autos to Women Drivers
Omega Seiki Mobility launches a CSR initiative offering 2,500 pink electric auto rickshaws at discounted prices to women drivers across India, aiming to empower women and promote sustainable...
Apr 10, 2025 11:00
Indian Job Market Resilient Despite Global Uncertainties
India's job market remains strong, driven by tech expertise, cost efficiency and upskilling, says Michael Page India. Learn about key sectors seeing hiring surges.
Apr 10, 2025 10:53

More Top News »

Sectoral Indices Market Indicators Listed Companies Gainers Losers Mutual Funds Portfolio Watchlist
© 2025 Rediff.com